Literature DB >> 1428795

The primary antiphospholipid syndrome: case report.

S Severi1, M Ghezzi, M Felici.   

Abstract

Lupus anticoagulant antibodies and anticardiolipin antibodies are acquired circulating immunoglobulins that interact with phospholipids. These factors may exert anticoagulant properties in vitro and so interfere with coagulation tests that use phospholipids. These antibodies are not, however, associated with a hemorrhagic diathesis. Indeed, despite their name and their in vitro anticoagulant properties, they have been associated right from the earliest reports with systemic and cerebral thromboembolic episodes. We report the clinical and instrumental findings in a patient with ischemic stroke and anticoagulant antibodies in the serum.

Entities:  

Mesh:

Year:  1992        PMID: 1428795     DOI: 10.1007/bf02233404

Source DB:  PubMed          Journal:  Ital J Neurol Sci        ISSN: 0392-0461


  9 in total

Review 1.  Antiphospholipid antibodies, prethrombotic states, and stroke.

Authors:  B M Coull; S H Goodnight
Journal:  Stroke       Date:  1990-09       Impact factor: 7.914

2.  Lupus anticoagulant and late onset seizures.

Authors:  R Inzelberg; A D Korczyn
Journal:  Acta Neurol Scand       Date:  1989-02       Impact factor: 3.209

3.  Frequency, etiology, and prevention of stroke in patients with systemic lupus erythematosus.

Authors:  N Futrell; C Millikan
Journal:  Stroke       Date:  1989-05       Impact factor: 7.914

4.  Clinical and laboratory findings in patients with antiphospholipid antibodies and cerebral ischemia. The Antiphospholipid Antibodies in Stroke Study Group.

Authors: 
Journal:  Stroke       Date:  1990-09       Impact factor: 7.914

Review 5.  Hematologic disorders and ischemic stroke. A selective review.

Authors:  R G Hart; M C Kanter
Journal:  Stroke       Date:  1990-08       Impact factor: 7.914

6.  Amaurosis fugax associated with antiphospholipid antibodies.

Authors:  K B Digre; F J Durcan; D W Branch; D M Jacobson; M W Varner; J R Baringer
Journal:  Ann Neurol       Date:  1989-03       Impact factor: 10.422

7.  Neurological disease associated with antiphospholipid antibodies.

Authors:  D P Briley; B M Coull; S H Goodnight
Journal:  Ann Neurol       Date:  1989-03       Impact factor: 10.422

8.  Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome.

Authors:  R A Asherson; M A Khamashta; A Gil; J J Vazquez; O Chan; E Baguley; G R Hughes
Journal:  Am J Med       Date:  1989-04       Impact factor: 4.965

9.  Lupus anticoagulants, anticardiolipin antibodies, and cerebral ischemia.

Authors:  M Kushner; N Simonian
Journal:  Stroke       Date:  1989-02       Impact factor: 7.914

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.